Critères de fragilité appliqués en oncogériatrie

Springer Science and Business Media LLC - Tập 3 Số 1 - Trang 20-25 - 2011
F. Rétornaz1, I. Potard1, C. Molines1, F. Rousseau2
1Unité pilote de coordination en oncogériatrie (UPCOG), centre gérontologique départemental, 1, rue Elzéard-Rougier, F-13012, Marseille, France
2Unité pilote de coordination en oncogériatrie (UPCOG), institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, F-13273, Marseille cedex 09, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hogan DB, MacKnight C, Bergman H (2003) Steering Committee, Canadian Initiative on Frailty and Aging. Models, definitions, and criteria of frailty. Aging Clin Exp Res 15(Suppl):1–29

Bergman H, Béland F, Karunananthan S, et al (2004) Développement d’un cadre de travail pour comprendre et étudier la fragilité. Gerontol Soc 15–29

Karunananthan S, Bergman H, Vedel I, Retornaz F (2009) La fragilité: en quête d’un nouveau paradigme clinique et de recherche pertinent. Rev Med Interne 30:105–109

Bergman H, Ferrucci L, Guralnik J, et al (2007) Frailty: an emerging research and clinical paradigm: issues and controversies. J Gerontol A Biol Sci Med Sci 62:731–737

Rockwood K, Song X, MacKnight C, et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173:489–495

Fried LP, Ferrucci L, Darer J, et al (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59: M255–M263

Fried LP, Tangen CM, Walston J, et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156

Bandeen-Roche K, Xue QL, Ferrucci L, et al (2006) Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci 61:262–266

Rothman MD, Leo-Summers L, Gill TM (2008) Prognostic significance of potential frailty criteria. J Am Geriatr Soc 56:2211–2216

Karunananthan S, Wolfson C, Bergman H, et al (2009) A multidisciplinary systematic literature review on frailty: overview of the methodology used by the Canadian Initiative on Frailty and Aging. BMC Med Res Methodol 9:68

Projet Frèle, disponible online sur http://www.frailty-research.ca/f/IRSC_PR2.htm , dernier accès le 12.01.11

Montero-Odasso M, Schapira M, Soriano ER, et al (2005) Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci 60:1304–1309

Abellan van Kan G, Rolland Y, Andrieu S, et al (2009) Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 13:881–889

Ensrud K, Ewing, S, Taylor B, et al (2008) Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. J Arch Intern Med 168:382–389

Ensrud K, Ewing S, Cawthon P, et al (2009) A comparison of frailty indexes for the prediction of falls, disability, fractures and mortality in older men. J Am Geriatr Soc 57:492–498

Extermann M, Aapro M, Bernabei R, et al (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55:241–252

Carreca I, Balducci L, Extermann M (2005) Cancer in the older person. Cancer Treat Rev 31:380–402

Balducci L, Beghe C (2000) The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 35:147–154

Bernabei R, Venturiero V, Tarsitani P, Gambassi G (2000) The comprehensive geriatric assessment: when, where, how. Crit Rev Oncol Hematol 33(1):45–56

Chen CC, Kenefick AL, Tang ST, McCorkle R (2004) Utilization of comprehensive geriatric assessment in cancer patients. Crit Rev Oncol Hematol 49(1):53–67

Misra D, Seo PH, Cohen HJ (2004) Aging and cancer. Clin Adv Hematol Oncol 2:457–465

Repetto L, Venturino A, Fratino L, et al (2003) Geriatric oncology: a clinical approach to the older patient with cancer. Eur J Cancer 39(7):870–880

Ghiringhelli F, Ladoire S, Manckoundia P, et al (2005) Prise en charge des cancers solides et des hémopathies malignes du sujet âgé: l’oncogériatrie une discipline en devenir. Première partie: l’évaluation gériatrique et la prise en charge des cancers solides. Rev Med Interne 26:216–225

Solomon D, Sue BA, Brummel-Smith K, et al (2003) Best paper of the 1980s: National Institutes of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision-making. 1988. J Am Geriatr Soc 51:1490–1494

Stuck AE, Siu AL, Wieland GD, et al (1993) Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 342:1032–1036

Ferrucci L, Guralnik JM, Cavazzini C, et al (2003) The frailty syndrome: a critical issue in geriatric oncology. Crit Rev Oncol Hematol 46:127–137

Serraino D, Fratino L, Zagonel V (2001) Prevalence of functional disability among elderly patients with cancer. Crit Rev Oncol Hematol 39:269–273

Repetto L, Fratino L, Audisio RA, et al (2002) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20:494–502

Roche RJ, Forman WB, Rhyne RL (1997) Formal geriatric assessment. An imperative for the older person with cancer. Cancer Pract 5:81–86

Repetto L, Venturino A, Vercelli M, et al (1998) Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions. Cancer 82:760–765

Retornaz F, Seux V, Sourial N, et al (2007) Comparison of health and functional status between elderly inpatients with and without cancer admitted to a geriatric/internal medicine unit. J Gerontol A Biol Sci Med Sci 62(8):917–922

Hurria A, Gupta S, Zauderer M, et al (2005) Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 104:1998–2005

Retornaz F, Monette J, Batist G, et al (2008) Usefulness of frailty markers in the assessment of health and functional status of older cancer patients referred for chemotherapy: a pilot study, J Gerontol A Biol Sci Med Sci 63:518–522

Puts MT, Monette J, Girre V, et al (2010) Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol 3: In press

Puts MT, Monette J, Girre V, et al (2010) Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study. Crit Rev Oncol Hematol 76:142–151

Makary MA, Segev DL, Pronovost PJ, et al (2010) Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 210:901–908

Gill TM, Gahbauer EA, Allore HG, Han L (2006) Transitions between frailty states among community-living older persons. Arch Intern Med 166:418–423